A common cholesterol drug may be the next breakthrough in advanced cancer treatment. The drug, called Lovastatin, was the first of the statin group of lipid fighters and was introduced in 1980. In lab tests, Lovastatin had an unexpected yet exciting side effect—it attacked cancer cells as well as lipids.
In order for Lovastatin to be effective against cancer tumors, the drug must be administered in doses too high for most patients to handle. Now scientists have found that a similar outcome can be achieved by combining safe doses of Lovastatin with other drugs like interferon.
The results so far have been encouraging. Several patients with late stage melanoma (an extremely fatal form of skin cancer) have seen tumors regress or disappear in a matter of weeks. In fact, the first patient to receive this experimental treatment had stage 4 melanoma that completely disappeared to leave him cancer-free to this day.
Flower Drum Song buy Researchers expect for this to transfer to several other cancers including pancreatic, colon and kidney cancer, as well as mesothelioma. It may also be effective against several osteosarcoma, chondrosarcoma and malignant fibrous histiocytoma. Unfortunately, they do not expect this treatment to be effective against tumors in the brain.
Of all the common side effects of chemotherapy, most patients undergoing the Levastatin treatment only experience fatigue.
This is an outpatient treatment. Previous cancer treatment does not make a person ineligible. If you would like to read more, visit www.neoplas.org <http://www.neoplas.org> .